Literature DB >> 22984888

Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.

Hassan Aryapour1, Gholam Hossein Riazi, Shahin Ahmadian, Alireza Foroumadi, Majid Mahdavi, Saeed Emami.   

Abstract

CONTEXT: As microtubules are highly involved in cellular growth, it appears to be a preferential target for cancer treatment. Therefore, many efforts have been performed to discover drugs that affect on microtubule function. Several microtubule inhibitors are in various stages of laboratory evaluations and clinical trials.
OBJECTIVE: A series of chromene-based chalcones with chlorine, methoxy, fluorine, tetrahydropyranyloxy and cyanide substituents were prepared and evaluated for cytotoxic effects against K562 and SK-N-MC cell lines, and the inhibitory effect on tubulin polymerization was studied as well.
MATERIALS AND METHODS: MTT, tubulin polymerization assays and binding measurements were evaluated by using related spectroscopy. Immunocytochemical study, morphological observations and apoptosis assay were examined using a fluorescence microscope and a flow cytometer.
RESULTS: (E)-3-(6-Chloro-2H-chromen-3-yl)-1-(3,4,5-trimethoxyphenyl) prop-2-en-1-one (compound 14) proved to be the most active in this series as an inhibitor of tubulin assembly [IC₅₀, 19.6 µM] and cytotoxic agent on K562 cells [IC₅₀, 38.7 µM]. Furthermore, these compounds exhibited a strong inhibitory effect on tubulin polymerization and reduced the in vitro assembly and bundling of proto-filaments. Also, compound 14 bound to the tubulin with a dissociation constant of 9.4 ± 0.7 µM and induced conformational changes in this protein. DISCUSSION AND
CONCLUSION: This study suggests that the compound 14 could be a good antitumor agent because of its biological functions. Compound 14 appears to bind directly to tubulin and thereby perturbs microtubule stability and the function of the spindle apparatus, which causes cancer cells to arrest and undergo apoptosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22984888     DOI: 10.3109/13880209.2012.695799

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  5 in total

1.  Synthesis, Evaluation for Cytotoxicity and Molecular Docking Studies of Benzo[c]furan-Chalcones for Potential to Inhibit Tubulin Polymerization and/or EGFR-Tyrosine Kinase Phosphorylation.

Authors:  Malose J Mphahlele; Marole M Maluleka; Nishal Parbhoo; Sibusiso T Malindisa
Journal:  Int J Mol Sci       Date:  2018-08-28       Impact factor: 5.923

Review 2.  A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.

Authors:  Wenjing Liu; Min He; Yongjun Li; Zhiyun Peng; Guangcheng Wang
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

3.  Synthesis and In vitro cytotoxic activity evaluation of (E)-16-(substituted benzylidene) derivatives of dehydroepiandrosterone.

Authors:  Mohsen Vosooghi; Hoda Yahyavi; Kouros Divsalar; Hashem Shamsa; Asma Kheirollahi; Maliheh Safavi; Sussan Kabudanian Ardestani; Sareh Sadeghi-Neshat; Negar Mohammadhosseini; Najmeh Edraki; Mehdi Khoshneviszadeh; Abbas Shafiee; Alireza Foroumadi
Journal:  Daru       Date:  2013-05-01       Impact factor: 3.117

4.  Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells.

Authors:  Somayeh Fani; Behnam Kamalidehghan; Kong Mun Lo; Najihah Mohd Hashim; Kit May Chow; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2015-11-23       Impact factor: 4.162

5.  Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion.

Authors:  Heather K Armstrong; Joanna L Gillis; Ian R D Johnson; Zeyad D Nassar; Max Moldovan; Claire Levrier; Martin C Sadowski; Mei Yieng Chin; Emma S Tomlinson Guns; Gerard Tarulli; David J Lynn; Douglas A Brooks; Luke A Selth; Margaret M Centenera; Lisa M Butler
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.